TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Gonzaga, I. M. AU - Soareslima, S. C. AU - Santos, P. T. AU - Blanco, T. C. AU - Reis, B. S. PY - 2012 DA - 2012// TI - Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-569 DO - 10.1186/1471-2407-12-569 ID - Gonzaga2012 ER - TY - JOUR AU - Fichter, C. D. AU - Gudernatsch, V. AU - Przypadlo, C. M. AU - Follo, M. AU - Schmidt, G. AU - Werner, M. PY - 2014 DA - 2014// TI - ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways JO - J Mol Med (Berl) VL - 92 UR - https://doi.org/10.1007/s00109-014-1187-5 DO - 10.1007/s00109-014-1187-5 ID - Fichter2014 ER - TY - JOUR AU - Shan, L. AU - Ying, J. AU - Lu, N. PY - 2013 DA - 2013// TI - HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population JO - Diagn Pathol VL - 8 UR - https://doi.org/10.1186/1746-1596-8-76 DO - 10.1186/1746-1596-8-76 ID - Shan2013 ER - TY - JOUR AU - Zhan, N. AU - Dong, W. AU - Tang, Y. AU - Wang, Z. AU - Xiong, C. PY - 2012 DA - 2012// TI - Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma JO - Med Oncol VL - 29 UR - https://doi.org/10.1007/s12032-011-9850-y DO - 10.1007/s12032-011-9850-y ID - Zhan2012 ER - TY - JOUR AU - Mimura, K. AU - Kono, K. AU - Hanawa, M. AU - Mitsui, F. AU - Sugai, H. AU - Miyagawa, N. PY - 2005 DA - 2005// TI - Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma JO - Br J Cancer VL - 92 UR - https://doi.org/10.1038/sj.bjc.6602499 DO - 10.1038/sj.bjc.6602499 ID - Mimura2005 ER - TY - JOUR AU - Sato-Kuwabara, Y. AU - Neves, J. I. AU - Fregnani, J. H. AU - Sallum, R. A. AU - Soares, F. A. PY - 2009 DA - 2009// TI - Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using fluorescence in situ hybridization (FISH) and immunohistochemistry JO - BMC Cancer VL - 9 UR - https://doi.org/10.1186/1471-2407-9-6 DO - 10.1186/1471-2407-9-6 ID - Sato-Kuwabara2009 ER - TY - JOUR AU - Rice, T. W. AU - Gress, D. M. AU - Patil, D. T. AU - Hofstetter, W. L. AU - Kelsen, D. P. AU - Blackstone, E. H. PY - 2017 DA - 2017// TI - Cancer of the esophagus and esophagogastric junction-major changes in the American joint committee on Cancer eighth edition cancer staging manual JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21399 DO - 10.3322/caac.21399 ID - Rice2017 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Hicks, D. G. AU - Dowsett, M. AU - McShane, L. M. AU - Allison, K. H. PY - 2013 DA - 2013// TI - Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.50.9984 DO - 10.1200/JCO.2013.50.9984 ID - Wolff2013 ER - TY - JOUR AU - Dreilich, M. AU - Wanders, A. AU - Brattstrom, D. AU - Bergstrom, S. AU - Hesselius, P. AU - Wagenius, G. PY - 2006 DA - 2006// TI - HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival JO - Dis Esophagus VL - 19 UR - https://doi.org/10.1111/j.1442-2050.2006.00570.x DO - 10.1111/j.1442-2050.2006.00570.x ID - Dreilich2006 ER - TY - JOUR AU - Nig, A. M. K. AU - Reeh, M. AU - Dancau, A. AU - Rathjens, M. AU - Gros, S. PY - 2013 DA - 2013// TI - Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma JO - Anticancer Res VL - 33 ID - Nig2013 ER - TY - JOUR AU - Kawaguchi, Y. AU - Kono, K. AU - Mimura, K. AU - Mitsui, F. AU - Sugai, H. AU - Akaike, H. PY - 2007 DA - 2007// TI - Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma JO - Br J Cancer VL - 97 UR - https://doi.org/10.1038/sj.bjc.6603885 DO - 10.1038/sj.bjc.6603885 ID - Kawaguchi2007 ER - TY - JOUR AU - Schoppmann, S. F. AU - Jesch, B. AU - Friedrich, J. AU - Wrba, F. AU - Schultheis, A. AU - Pluschnig, U. PY - 2010 DA - 2010// TI - Expression of her-2 in carcinomas of the esophagus JO - Am J Surg Pathol VL - 34 UR - https://doi.org/10.1097/PAS.0b013e3181f8be17 DO - 10.1097/PAS.0b013e3181f8be17 ID - Schoppmann2010 ER - TY - JOUR AU - Gibault, L. AU - Metges, J. P. AU - Conan-Charlet, V. AU - Lozac'H, P. AU - Robaszkiewicz, M. AU - Bessaguet, C. PY - 2005 DA - 2005// TI - Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602625 DO - 10.1038/sj.bjc.6602625 ID - Gibault2005 ER - TY - JOUR AU - Hatogai, K. AU - Fujii, S. AU - Kojima, T. AU - Daiko, H. AU - Nomura, S. AU - Doi, T. PY - 2017 DA - 2017// TI - Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma JO - J Cancer Res Clin Oncol VL - 143 UR - https://doi.org/10.1007/s00432-017-2482-7 DO - 10.1007/s00432-017-2482-7 ID - Hatogai2017 ER - TY - JOUR AU - Shibata-Kobayashi, S. AU - Yamashita, H. AU - Okuma, K. AU - Shiraishi, K. AU - Igaki, H. AU - Ohtomo, K. PY - 2013 DA - 2013// TI - Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-alpha, NF-kappaB, TGF-beta, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1alpha] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma JO - Oncol Lett VL - 5 UR - https://doi.org/10.3892/ol.2013.1130 DO - 10.3892/ol.2013.1130 ID - Shibata-Kobayashi2013 ER - TY - JOUR AU - Akamatsu, M. AU - Matsumoto, T. AU - Oka, K. AU - Yamasaki, S. AU - Sonoue, H. AU - Kajiyama, Y. PY - 2003 DA - 2003// TI - c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma JO - Int J Radiat Oncol Biol Phys VL - 57 UR - https://doi.org/10.1016/s0360-3016(03)00782-x DO - 10.1016/s0360-3016(03)00782-x ID - Akamatsu2003 ER - TY - JOUR AU - Bartley, A. N. AU - Washington, M. K. AU - Colasacco, C. AU - Ventura, C. B. AU - Ismaila, N. AU - Benson, A. R. PY - 2017 DA - 2017// TI - HER2 testing and clinical decision making in Gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.69.4836 DO - 10.1200/JCO.2016.69.4836 ID - Bartley2017 ER - TY - JOUR AU - Chen, Y. AU - Zhu, S. AU - Xu, X. AU - Zhao, A. N. AU - Hu, J. PY - 2016 DA - 2016// TI - Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinoma JO - Oncol Lett VL - 11 UR - https://doi.org/10.3892/ol.2015.3975 DO - 10.3892/ol.2015.3975 ID - Chen2016 ER - TY - JOUR AU - Fazlollahi, L. AU - Remotti, H. E. AU - Iuga, A. AU - Yang, H. M. AU - Lagana, S. M. AU - Sepulveda, A. R. PY - 2018 DA - 2018// TI - HER2 heterogeneity in Gastroesophageal Cancer detected by testing biopsy and resection specimens JO - Arch Pathol Lab Med VL - 142 UR - https://doi.org/10.5858/arpa.2017-0039-OA DO - 10.5858/arpa.2017-0039-OA ID - Fazlollahi2018 ER - TY - JOUR AU - Sunpaweravong, P. AU - Sunpaweravong, S. AU - Puttawibul, P. AU - Mitarnun, W. AU - Zeng, C. AU - Baron, A. E. PY - 2005 DA - 2005// TI - Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma JO - J Cancer Res Clin Oncol VL - 131 UR - https://doi.org/10.1007/s00432-004-0610-7 DO - 10.1007/s00432-004-0610-7 ID - Sunpaweravong2005 ER - TY - JOUR AU - Horii, R. AU - Matsuura, M. AU - Iwase, T. AU - Ito, Y. AU - Akiyama, F. PY - 2014 DA - 2014// TI - Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer JO - Breast Cancer VL - 21 UR - https://doi.org/10.1007/s12282-012-0436-0 DO - 10.1007/s12282-012-0436-0 ID - Horii2014 ER - TY - JOUR AU - Fusco, N. AU - Bosari, S. PY - 2016 DA - 2016// TI - HER2 aberrations and heterogeneity in cancers of the digestive system: implications for pathologists and gastroenterologists JO - World J Gastroenterol VL - 22 UR - https://doi.org/10.3748/wjg.v22.i35.7926 DO - 10.3748/wjg.v22.i35.7926 ID - Fusco2016 ER - TY - JOUR AU - Krishnamurti, U. AU - Silverman, J. F. PY - 2014 DA - 2014// TI - HER2 in breast cancer: a review and update JO - Adv Anat Pathol VL - 21 UR - https://doi.org/10.1097/PAP.0000000000000015 DO - 10.1097/PAP.0000000000000015 ID - Krishnamurti2014 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. H. AU - Allison, K. H. AU - Harvey, B. E. AU - Mangu, P. B. AU - Bartlett, J. M. S. PY - 2018 DA - 2018// TI - Human epidermal growth factor receptor 2 testing in breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2018.77.8738 DO - 10.1200/JCO.2018.77.8738 ID - Wolff2018 ER - TY - JOUR AU - Bang, Y. J. AU - Cutsem, E. AU - Feyereislova, A. AU - Chung, H. C. AU - Shen, L. AU - Sawaki, A. PY - 2010 DA - 2010// TI - Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial JO - Lancet. VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61121-X DO - 10.1016/S0140-6736(10)61121-X ID - Bang2010 ER - TY - JOUR AU - Kasper, S. AU - Schuler, M. PY - 2014 DA - 2014// TI - Targeted therapies in gastroesophageal cancer JO - Eur J Cancer VL - 50 UR - https://doi.org/10.1016/j.ejca.2014.01.009 DO - 10.1016/j.ejca.2014.01.009 ID - Kasper2014 ER - TY - JOUR AU - Mimura, K. AU - Izawa, S. AU - Siba, S. AU - Maruyama, T. AU - Watanabe, M. AU - Kawaguchi, Y. PY - 2011 DA - 2011// TI - The effect of immune-based therapy with cytotoxic T lymphocyte and molecular targeting therapy for HER2 in esophageal squamous cell carcinoma JO - Gan To Kagaku Ryoho VL - 38 ID - Mimura2011 ER - TY - JOUR AU - Zhang, L. AU - Ma, J. AU - Han, Y. AU - Liu, J. AU - Zhou, W. AU - Hong, L. PY - 2016 DA - 2016// TI - Targeted therapy in esophageal cancer JO - Expert Rev Gastroenterol Hepatol VL - 10 UR - https://doi.org/10.1586/17474124.2016.1140036 DO - 10.1586/17474124.2016.1140036 ID - Zhang2016 ER -